SCHEMBL23201007

SCHEMBL23201007

CC(C)(C)OC(=O)c1c(O)c(Br)cc(F)c1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.36
CA1 P00915 3/20 0.34
CA2 P00918 3/20 0.34
CA4 P22748 2/20 0.34
TSHR P16473 2/20 0.34
HIF1A Q16665 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP3A4 P08684 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
ALOX12 P18054 1/20 0.34
CASP1 P29466 1/20 0.34
RECQL P46063 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SOS1 Q07889 1/20 0.32
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6233293 0.85 CA1 (0.37) CA1CA2CA4TDP1CYP2C9
SCHEMBL31354778 0.85 AAK1 (0.38) AAK1CA1CA2CA4CYP2C9
SCHEMBL23200607 0.82 HSD17B10 (0.36) AAK1CA1CA2CA4TSHR
SCHEMBL17337327 0.81 CA1 (0.34) CA1CA2CA4CYP2C9CYP2C19
SCHEMBL22982859 0.81 AAK1 (0.37) AAK1CA1CA2CYP2C9CYP2C19
SCHEMBL15867204 0.79 CA12 (0.35) AAK1CA1CA2TSHRALOX15
SCHEMBL26879383 0.78 CES2 (0.36) AAK1CA1CA2TSHRRECQL
SCHEMBL30322424 0.78 CES2 (0.36) AAK1CA1CA2TSHRRECQL
SCHEMBL31354768 0.77 CYP2C9 (0.35) CA1CA2CA4CYP3A4TDP1
SCHEMBL679953 0.76 CA1 (0.41) CA1CA2CA4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12173018-B2 Penicillin-binding protein inhibitors VenatoRx Pharmaceuticals, Inc. (US) 2024-12-24 US disclosed
US-20210198288-A1 PENICILLIN-BINDING PROTEIN INHIBITORS VenatoRx Pharmaceuticals, Inc. 2021-07-01 US disclosed
US-20210198288-A1 PENICILLIN-BINDING PROTEIN INHIBITORS VenatoRx Pharmaceuticals, Inc. 2021-07-01 US disclosed
EP-3802551-A1 PENICILLIN-BINDING PROTEIN INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-04-14 EP disclosed
CN-112469725-A Penicillin binding protein inhibitors 维纳拓尔斯制药公司 2021-03-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198288-A1 PENICILLIN-BINDING PROTEIN INHIBITORS PEPD, BPGM, EBPL AAK1 1642/4885CA1 3021/4885CA2 2155/4885
US-12173018-B2 Penicillin-binding protein inhibitors PEPD, BPGM, EBPL AAK1 1642/4885CA1 3021/4885CA2 2155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.